Fig. 3From: Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohortGlucose-lowering treatments across quintiles. Percentage of individuals per quintile untreated (a), on metformin only (b), combination of metformin and SU (c), SU monotherapy (d) and insulin (e). Odds ratios of four highest quintiles versus the lowest quintile across time for f metformin, g sulphonylureas and h insulin. SU sulphonylureasBack to article page